Article, 2024

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

INFLUENZA AND OTHER RESPIRATORY VIRUSES, ISSN 1750-2640, Volume 18, 4, 10.1111/irv.13292

Contributors

Monge, Susana (Corresponding author) [1] [2] Humphreys, J. [3] Nicolay, Nathalie [4] Braeye, T. [5] Van Evercooren, Izaak [5] Hansen, Christian Holm [6] Emborg, Hanne-Dorthe [6] Sacco, Chiara 0000-0002-3958-8353 [4] [7] Mateo-Urdiales, Alberto [7] Castilla, Jesus 0000-0002-6396-7265 [8] [9] [10] Martinez-Baz, Ivan [8] [9] [10] de Gier, B. [11] Hahne, Susan [11] Meijerink, H. [12] Kristoffersen, A. B. [12] Machado, Ausenda [13] Soares, Patricia 0000-0002-8765-0545 [13] Nardone, Anthony [3] Bacci, Sabrina [4] Kissling, Esther [3] Nunes, Baltazar 0000-0001-6230-7209 [3] VEBIS EHR Working Grp

Affiliations

  1. [1] CIBER Infect Dis, Madrid, Spain
    2. [NORA names: Spain; Europe, EU; OECD];
  2. [2] Inst Hlth Carlos III, Natl Ctr Epidemiol, Dept Communicable Dis, Madrid, Spain
    3. [NORA names: Spain; Europe, EU; OECD];
  3. [3] EpiConcept, Paris, France
    4. [NORA names: France; Europe, EU; OECD];
  4. [4] European Ctr Dis Prevent & Control ECDC, Vaccine Preventable Dis & Immunisat, Solna, Sweden
    5. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  5. [5] Sciensano, Elsene, Belgium
    6. [NORA names: Belgium; Europe, EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

COVID-19, SARS-CoV-2, cohort design, electronic health records, hospitalisation, multicountry study, vaccine effectiveness

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+